Zepbound 15 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FJG3V
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,871
Award facts
- Contract value 100% obligated
- $19,871.09 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $19,871.09 to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 15 mg/0.5 mL pens on January 6, 2026. This is a firm fixed-price, non-set-aside contract with a completion date of January 7, 2026, with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. The award represents a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s significant Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031, which serves as the primary vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp functions as a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving military and veteran healthcare systems through the Defense Logistics Agency. The company's extensive portfolio includes diabetes medications, specialty pharmaceuticals, vaccines, and medical devices across multiple therapeutic domains. This delivery order for Zepbound demonstrates the contractor's role in supplying specialized pharmaceutical commodities to support the Department of Defense's healthcare requirements, with the medication commonly used for weight management in military treatment facilities and veterans' healthcare programs.
Quick answers
Who was awarded contract SPE2DR26FJG3V?
SPE2DR26FJG3V was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26FJG3V worth?
The government has obligated $19,871 on SPE2DR26FJG3V.
Is contract SPE2DR26FJG3V an order under another contract?
Yes. SPE2DR26FJG3V is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJG3V competed?
The extent of competition for SPE2DR26FJG3V was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award